CORRESPONDENCE_1978-2005 - Laserfiche WebLink

Home Browse Search

Stag of California -Health and Human Servi gency Department of Health Services Page 3 of 4 pages RADIOACTIVE MATERIAL LICENSE License Number: 1812-39 Amendment Number: 53 17. Where users or their assistants are engaged in elution of pertechnetate 99m from generators, the exposure to the fingers or hands shall be monitored as required by Title 10, Code of Federal Regulations, Part 20, Section 20.1502 (a). 18. The licensee is authorized to hold radioactive materials with a physical half-life of less than 65 days for decay in storage before disposal in ordinary trash provided: (a) Radioactive waste to be disposed of in this manner shall be held for decay in storage for at least 10 half-lives. (b) Before disposal as normal waste, radioactive waste shall be surveyed to determine that its radioactivity cannot be distinguished from background. All radiation labels shall be removed or obliterated. (c) Generator columns shall be segregated so that they may be monitored separately to ensure decay to background levels prior to disposal. 19. The licensee may use one constancy source for the dose calibrator constancy test provided that the dose calibrator manual indicates that only one constancy source is needed for proper Quality Control. 20. The licensee may use any commercially available device, acceptable to the U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State, for doing linearity tests of its dose calibrator provided the procedures described by the manufacturer of the linearity device are followed. 21. Nuclear medicine technology procedures shall be performed by nuclear medicine technologists pursuant to Title 17, California Code of Regulations, Subchapter 4.6. Such procedures shall be performed under the supervision of authorized user physicians on this license who meet the criteria specified in Section 30510. Certificates or special permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the facility(ies) authorized on this license. 22. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall be in accordance with the guidance from any of the following: (a) Chapter 4, "Release from Hospital of Patients Containing Radioactive Material" National Council on Radiation Protection and Measurements (NCRP) Report No. 37, "Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides" (NCRP Publications, P.O. Box 30175, Washington, D.C. 20014). (b) Appendix M in the "Guide for the Preparation of Applications for Medical Programs", State of California, Department of Health Services, Radiological Health Branch. (c) Documented rationale or patient -specific calculations demonstrating that members of the general public will be limited to 500 mrem total effective dose equivalent from patients who have been released containing therapeutic quantities of radiopharmaceuticals. 23. Production or processing of radiopharmaceuticals for the purpose of commercial distribution to other licensees is not authorized by this license. 24. For a period not to exceed 60 days in any calendar year, a visiting physician is authorized to use licensed materials for human use under the terms of this license, provided the visiting physician: (a) Has the prior written permission of the hospital's Administrator and its Radiation Safety Committee. (b) Is specifically named as a user on a U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State license authorizing human use.